White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.

Not recruiting

4 1 1
Investigated Diseases:
- Graft versus host disease
Investigated Drugs:
- Human Alpha1-Proteinase Inhibitor
Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Autogene Cevumeran
- Pembrolizumab
Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Not recruiting

3 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Selpercatinib
+8
Study of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases

Not recruiting

2 1 1
Investigated Diseases:
- HER2 negative breast cancer
- Metastases to central nervous system
Investigated Drugs:
- Trastuzumab Deruxtecan
Study of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Not recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone-dependent prostate cancer
Investigated Drugs:
Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
- Acalabrutinib
+3
Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

Not recruiting

2 1
Investigated Diseases:
- Cognitive disorder
- Schizophrenia
Investigated Drugs:
- (2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
Study of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma

Not recruiting

4 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of skin
Investigated Drugs:
- Mrna-4157
- Pembrolizumab
+4
Study of Venetoclax, Daratumumab, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

1 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies